Perrigo (PRGO) Other financing activities (2013 - 2026)
Perrigo (PRGO) posted quarterly Other financing activities of -$500000.0 for Q1 2026, little changed year-over-year from -$500000.0 in Q1 2025, and up 90.91% quarter-over-quarter from -$5.5 million in Q4 2025.
Perrigo (PRGO) Other financing activities (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Other financing activities for 14 consecutive years, with -$500000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities changed 0.0% year-over-year to -$500000.0; the TTM figure through Mar 2026 stood at -$7.3 million (down 160.83% YoY), while the FY2025 annual figure was -$7.3 million, down 1360.0% from the prior year.
- Other financing activities improved to -$500000.0 in Q1 2026 per PRGO's latest filing, from -$5.5 million in the prior quarter.
- Across five years, Other financing activities topped out at $18.0 million in Q4 2023 and bottomed at -$18.2 million in Q2 2025.
- Historically, Other financing activities has averaged -$964705.9 across 5 years, with a median of -$2.2 million in 2022.
- Annual changes were most pronounced in 2023 — Other financing activities surged 500.0% — and 2025, when it slumped 787.5%.
- Perrigo's Other financing activities stood at $3.0 million in 2022, then soared by 500.0% to $18.0 million in 2023, then sank by 95.56% to $800000.0 in 2024, then plunged by 787.5% to -$5.5 million in 2025, then jumped by 90.91% to -$500000.0 in 2026.
- Business Quant data shows PRGO's Other financing activities at -$500000.0 in Q1 2026, -$5.5 million in Q4 2025, and $16.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Perrigo | 1.93 Bn | 1.54 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -9.40 Mn |
| Jun 27, 2026 | -9.40 Mn |
| Mar 28, 2026 | -500,000.00 |
| Mar 28, 2026 | -500,000.00 |
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Sep 27, 2025 | 16.90 Mn |
| Sep 27, 2025 | 16.90 Mn |
| Jun 28, 2025 | -18.20 Mn |
| Jun 28, 2025 | -18.20 Mn |
| Mar 29, 2025 | -500,000.00 |
| Mar 29, 2025 | -500,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 28, 2024 | 14.00 Mn |
| Sep 28, 2024 | 14.00 Mn |
| Jun 29, 2024 | -2.30 Mn |
| Jun 29, 2024 | -2.30 Mn |
| Mar 30, 2024 | -13.00 Mn |
| Mar 30, 2024 | -13.00 Mn |